The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases

@article{Wright2015TheDO,
  title={The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases},
  author={J. Wright and Leen H. Kawas and J. Harding},
  journal={Progress in Neurobiology},
  year={2015},
  volume={125},
  pages={26-46}
}
  • J. Wright, Leen H. Kawas, J. Harding
  • Published 2015
  • Psychology, Medicine
  • Progress in Neurobiology
  • Alzheimer's (AD) and Parkinson's (PD) diseases are neurodegenerative diseases presently without effective drug treatments. AD is characterized by general cognitive impairment, difficulties with memory consolidation and retrieval, and with advanced stages episodes of agitation and anger. AD is increasing in frequency as life expectancy increases. Present FDA approved medications do little to slow disease progression and none address the underlying progressive loss of synaptic connections and… CONTINUE READING
    36 Citations
    The Development of Small Molecule Angiotensin IV-Based Analogs to Treat Depression
    Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease
    • 12
    Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease
    • 22
    • PDF
    Neurovascular and Cognitive failure in Alzheimer’s Disease: Benefits of Cardiovascular Therapy
    • 26
    Small Molecule AngIV-based Analogs to Treat Alzheimers Disease
    Neuroprotective effects of geniposide on Alzheimer’s disease pathology
    • 28
    • PDF

    References

    SHOWING 1-10 OF 386 REFERENCES
    Importance of the Brain Angiotensin System in Parkinson's Disease
    • 21
    • PDF
    The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease
    • 54
    Angiotensin as a target for the treatment of Alzheimer’s disease, anxiety and depression
    • P. Gard
    • Medicine, Biology
    • Expert opinion on therapeutic targets
    • 2004
    • 87
    The role of the central renin-angiotensin system in Parkinson’s disease
    • 63
    • PDF
    Current treatment and recent clinical research in Alzheimer's disease.
    • 70